Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Uveal Melanoma 1 Recurrence 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Chronic 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Graft vs Host Disease 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclosporine 5 Cyclophosphamide 5 Busulfan 4 fludarabine phosphate 3 fludarabine 3 Mycophenolic Acid 3 thymoglobulin 2 Methotrexate 2 Antilymphocyte Serum 2 venetoclax 1 trihexyltetradecylphosphonium chloride 1 treosulfan 1 tocilizumab 1 Whole-Body Irradiation 1 Thiotepa 1 Tacrolimus 1 Sirolimus 1 Semustine 1 Rituximab 1 Radiotherapy 1 Polymerase Chain Reaction 1 Physical Therapy Modalities 1 Peripheral Blood Stem Cell Transplantation 1 Maraviroc 1 Interferon alpha-2 1 Immunoenzyme Techniques 1 Drug Therapy 1 Decitabine 1 Cytarabine 1 Cyclosporins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Graft vs Host Disease × treosulfan × Clear all

NCT01810926 2013-03-14

T&B Depletion Non Malignant

Bambino Gesù Hospital and Research Institute

Phase 2 Unknown

Graft vs Host Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡